A new study published in The Lancet journal has revealed that more than half of the heart patients around the world have no access to cheap drugs that can save their lives.
The study was led by Dr Salim Yusuf of Canada's McMaster University who revealed that more than 60 percent of heart patients in the world are unable to get cheap drugs. The situation is even worse among low income countries with over 80 percent of the patients not able to get the drugs.
The researchers observed more than 153,000 patients on five different continents and found that less than a quarter of the patients were able to take preventive medicines.
The researchers found that just over 25 percent of the patients took blood thinners such as aspirin while only 17.4 percent managed to get beta-blockers. ACE inhibitors were taken by less than 19.5 percent of the patients while just over 14 percent took statins.